Global Adalimumab Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[23][24][25] It is administered by injection under the skin.
The Adalimumab Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Adalimumab Drug market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Adalimumab Drug market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Adult occupied for % of the Adalimumab Drug global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Adalimumab segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Adalimumab Drug include Cambridge Antibody Technology, BASF, AbbVie, MABURA and Exemptia, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Adalimumab Drug market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Adalimumab Drug companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Adalimumab Drug market based on the following parameters – headquarters, products portfolio, Adalimumab Drug revenue and gross margin, recent developments.
Evaluation and forecast the Adalimumab Drug market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Adalimumab Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Chapter 1, to describe Adalimumab Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Adalimumab Drug, with revenue, gross margin and global market share of Adalimumab Drug from 2019 to 2022.
Chapter 3, the Adalimumab Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Adalimumab Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Adalimumab Drug research findings and conclusion, appendix and data source.
The Adalimumab Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Adalimumab Drug market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Adalimumab Drug market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Adult occupied for % of the Adalimumab Drug global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Adalimumab segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Adalimumab Drug include Cambridge Antibody Technology, BASF, AbbVie, MABURA and Exemptia, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Adalimumab Drug market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Adalimumab Drug companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Adalimumab Drug market based on the following parameters – headquarters, products portfolio, Adalimumab Drug revenue and gross margin, recent developments.
Evaluation and forecast the Adalimumab Drug market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Adalimumab Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
- Adalimumab
- Adalimumab Biosimilar
- Adult
- Children
- Cambridge Antibody Technology
- BASF
- AbbVie
- MABURA
- Exemptia
- Amgen
- Sandoz
- Boehringer Ingelheim
- Mylan
- Biogen
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
- South America (Brazil, Argentina, Colombia and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
Chapter 1, to describe Adalimumab Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Adalimumab Drug, with revenue, gross margin and global market share of Adalimumab Drug from 2019 to 2022.
Chapter 3, the Adalimumab Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Adalimumab Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Adalimumab Drug research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Adalimumab Drug
1.2 Classification of Adalimumab Drug by Type
1.2.1 Overview: Global Adalimumab Drug Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Adalimumab Drug Revenue Market Share by Type in 2021
1.2.3 Adalimumab
1.2.4 Adalimumab Biosimilar
1.3 Global Adalimumab Drug Market by Application
1.3.1 Overview: Global Adalimumab Drug Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adult
1.3.3 Children
1.4 Global Adalimumab Drug Market Size & Forecast
1.5 Global Adalimumab Drug Market Size and Forecast by Region
1.5.1 Global Adalimumab Drug Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Adalimumab Drug Market Size by Region, (2017-2022)
1.5.3 North America Adalimumab Drug Market Size and Prospect (2017-2028)
1.5.4 Europe Adalimumab Drug Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Adalimumab Drug Market Size and Prospect (2017-2028)
1.5.6 South America Adalimumab Drug Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Adalimumab Drug Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Adalimumab Drug Market Drivers
1.6.2 Adalimumab Drug Market Restraints
1.6.3 Adalimumab Drug Trends Analysis
2 COMPANY PROFILES
2.1 Cambridge Antibody Technology
2.1.1 Cambridge Antibody Technology Details
2.1.2 Cambridge Antibody Technology Major Business
2.1.3 Cambridge Antibody Technology Adalimumab Drug Product and Solutions
2.1.4 Cambridge Antibody Technology Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Cambridge Antibody Technology Recent Developments and Future Plans
2.2 BASF
2.2.1 BASF Details
2.2.2 BASF Major Business
2.2.3 BASF Adalimumab Drug Product and Solutions
2.2.4 BASF Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 BASF Recent Developments and Future Plans
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Adalimumab Drug Product and Solutions
2.3.4 AbbVie Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 AbbVie Recent Developments and Future Plans
2.4 MABURA
2.4.1 MABURA Details
2.4.2 MABURA Major Business
2.4.3 MABURA Adalimumab Drug Product and Solutions
2.4.4 MABURA Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 MABURA Recent Developments and Future Plans
2.5 Exemptia
2.5.1 Exemptia Details
2.5.2 Exemptia Major Business
2.5.3 Exemptia Adalimumab Drug Product and Solutions
2.5.4 Exemptia Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Exemptia Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Adalimumab Drug Product and Solutions
2.6.4 Amgen Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Adalimumab Drug Product and Solutions
2.7.4 Sandoz Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Sandoz Recent Developments and Future Plans
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Adalimumab Drug Product and Solutions
2.8.4 Boehringer Ingelheim Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Adalimumab Drug Product and Solutions
2.9.4 Mylan Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Mylan Recent Developments and Future Plans
2.10 Biogen
2.10.1 Biogen Details
2.10.2 Biogen Major Business
2.10.3 Biogen Adalimumab Drug Product and Solutions
2.10.4 Biogen Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Biogen Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Adalimumab Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Adalimumab Drug Players Market Share in 2021
3.2.2 Top 10 Adalimumab Drug Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Adalimumab Drug Players Head Office, Products and Services Provided
3.4 Adalimumab Drug Mergers & Acquisitions
3.5 Adalimumab Drug New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Adalimumab Drug Revenue and Market Share by Type (2017-2022)
4.2 Global Adalimumab Drug Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Adalimumab Drug Revenue Market Share by Application (2017-2022)
5.2 Global Adalimumab Drug Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Adalimumab Drug Revenue by Type (2017-2028)
6.2 North America Adalimumab Drug Revenue by Application (2017-2028)
6.3 North America Adalimumab Drug Market Size by Country
6.3.1 North America Adalimumab Drug Revenue by Country (2017-2028)
6.3.2 United States Adalimumab Drug Market Size and Forecast (2017-2028)
6.3.3 Canada Adalimumab Drug Market Size and Forecast (2017-2028)
6.3.4 Mexico Adalimumab Drug Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Adalimumab Drug Revenue by Type (2017-2028)
7.2 Europe Adalimumab Drug Revenue by Application (2017-2028)
7.3 Europe Adalimumab Drug Market Size by Country
7.3.1 Europe Adalimumab Drug Revenue by Country (2017-2028)
7.3.2 Germany Adalimumab Drug Market Size and Forecast (2017-2028)
7.3.3 France Adalimumab Drug Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Adalimumab Drug Market Size and Forecast (2017-2028)
7.3.5 Russia Adalimumab Drug Market Size and Forecast (2017-2028)
7.3.6 Italy Adalimumab Drug Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Adalimumab Drug Revenue by Type (2017-2028)
8.2 Asia-Pacific Adalimumab Drug Revenue by Application (2017-2028)
8.3 Asia-Pacific Adalimumab Drug Market Size by Region
8.3.1 Asia-Pacific Adalimumab Drug Revenue by Region (2017-2028)
8.3.2 China Adalimumab Drug Market Size and Forecast (2017-2028)
8.3.3 Japan Adalimumab Drug Market Size and Forecast (2017-2028)
8.3.4 South Korea Adalimumab Drug Market Size and Forecast (2017-2028)
8.3.5 India Adalimumab Drug Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Adalimumab Drug Market Size and Forecast (2017-2028)
8.3.7 Australia Adalimumab Drug Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Adalimumab Drug Revenue by Type (2017-2028)
9.2 South America Adalimumab Drug Revenue by Application (2017-2028)
9.3 South America Adalimumab Drug Market Size by Country
9.3.1 South America Adalimumab Drug Revenue by Country (2017-2028)
9.3.2 Brazil Adalimumab Drug Market Size and Forecast (2017-2028)
9.3.3 Argentina Adalimumab Drug Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Adalimumab Drug Revenue by Type (2017-2028)
10.2 Middle East & Africa Adalimumab Drug Revenue by Application (2017-2028)
10.3 Middle East & Africa Adalimumab Drug Market Size by Country
10.3.1 Middle East & Africa Adalimumab Drug Revenue by Country (2017-2028)
10.3.2 Turkey Adalimumab Drug Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Adalimumab Drug Market Size and Forecast (2017-2028)
10.3.4 UAE Adalimumab Drug Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Adalimumab Drug
1.2 Classification of Adalimumab Drug by Type
1.2.1 Overview: Global Adalimumab Drug Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Adalimumab Drug Revenue Market Share by Type in 2021
1.2.3 Adalimumab
1.2.4 Adalimumab Biosimilar
1.3 Global Adalimumab Drug Market by Application
1.3.1 Overview: Global Adalimumab Drug Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adult
1.3.3 Children
1.4 Global Adalimumab Drug Market Size & Forecast
1.5 Global Adalimumab Drug Market Size and Forecast by Region
1.5.1 Global Adalimumab Drug Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Adalimumab Drug Market Size by Region, (2017-2022)
1.5.3 North America Adalimumab Drug Market Size and Prospect (2017-2028)
1.5.4 Europe Adalimumab Drug Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Adalimumab Drug Market Size and Prospect (2017-2028)
1.5.6 South America Adalimumab Drug Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Adalimumab Drug Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Adalimumab Drug Market Drivers
1.6.2 Adalimumab Drug Market Restraints
1.6.3 Adalimumab Drug Trends Analysis
2 COMPANY PROFILES
2.1 Cambridge Antibody Technology
2.1.1 Cambridge Antibody Technology Details
2.1.2 Cambridge Antibody Technology Major Business
2.1.3 Cambridge Antibody Technology Adalimumab Drug Product and Solutions
2.1.4 Cambridge Antibody Technology Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Cambridge Antibody Technology Recent Developments and Future Plans
2.2 BASF
2.2.1 BASF Details
2.2.2 BASF Major Business
2.2.3 BASF Adalimumab Drug Product and Solutions
2.2.4 BASF Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 BASF Recent Developments and Future Plans
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Adalimumab Drug Product and Solutions
2.3.4 AbbVie Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 AbbVie Recent Developments and Future Plans
2.4 MABURA
2.4.1 MABURA Details
2.4.2 MABURA Major Business
2.4.3 MABURA Adalimumab Drug Product and Solutions
2.4.4 MABURA Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 MABURA Recent Developments and Future Plans
2.5 Exemptia
2.5.1 Exemptia Details
2.5.2 Exemptia Major Business
2.5.3 Exemptia Adalimumab Drug Product and Solutions
2.5.4 Exemptia Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Exemptia Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Adalimumab Drug Product and Solutions
2.6.4 Amgen Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Adalimumab Drug Product and Solutions
2.7.4 Sandoz Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Sandoz Recent Developments and Future Plans
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Adalimumab Drug Product and Solutions
2.8.4 Boehringer Ingelheim Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Adalimumab Drug Product and Solutions
2.9.4 Mylan Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Mylan Recent Developments and Future Plans
2.10 Biogen
2.10.1 Biogen Details
2.10.2 Biogen Major Business
2.10.3 Biogen Adalimumab Drug Product and Solutions
2.10.4 Biogen Adalimumab Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Biogen Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Adalimumab Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Adalimumab Drug Players Market Share in 2021
3.2.2 Top 10 Adalimumab Drug Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Adalimumab Drug Players Head Office, Products and Services Provided
3.4 Adalimumab Drug Mergers & Acquisitions
3.5 Adalimumab Drug New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Adalimumab Drug Revenue and Market Share by Type (2017-2022)
4.2 Global Adalimumab Drug Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Adalimumab Drug Revenue Market Share by Application (2017-2022)
5.2 Global Adalimumab Drug Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Adalimumab Drug Revenue by Type (2017-2028)
6.2 North America Adalimumab Drug Revenue by Application (2017-2028)
6.3 North America Adalimumab Drug Market Size by Country
6.3.1 North America Adalimumab Drug Revenue by Country (2017-2028)
6.3.2 United States Adalimumab Drug Market Size and Forecast (2017-2028)
6.3.3 Canada Adalimumab Drug Market Size and Forecast (2017-2028)
6.3.4 Mexico Adalimumab Drug Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Adalimumab Drug Revenue by Type (2017-2028)
7.2 Europe Adalimumab Drug Revenue by Application (2017-2028)
7.3 Europe Adalimumab Drug Market Size by Country
7.3.1 Europe Adalimumab Drug Revenue by Country (2017-2028)
7.3.2 Germany Adalimumab Drug Market Size and Forecast (2017-2028)
7.3.3 France Adalimumab Drug Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Adalimumab Drug Market Size and Forecast (2017-2028)
7.3.5 Russia Adalimumab Drug Market Size and Forecast (2017-2028)
7.3.6 Italy Adalimumab Drug Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Adalimumab Drug Revenue by Type (2017-2028)
8.2 Asia-Pacific Adalimumab Drug Revenue by Application (2017-2028)
8.3 Asia-Pacific Adalimumab Drug Market Size by Region
8.3.1 Asia-Pacific Adalimumab Drug Revenue by Region (2017-2028)
8.3.2 China Adalimumab Drug Market Size and Forecast (2017-2028)
8.3.3 Japan Adalimumab Drug Market Size and Forecast (2017-2028)
8.3.4 South Korea Adalimumab Drug Market Size and Forecast (2017-2028)
8.3.5 India Adalimumab Drug Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Adalimumab Drug Market Size and Forecast (2017-2028)
8.3.7 Australia Adalimumab Drug Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Adalimumab Drug Revenue by Type (2017-2028)
9.2 South America Adalimumab Drug Revenue by Application (2017-2028)
9.3 South America Adalimumab Drug Market Size by Country
9.3.1 South America Adalimumab Drug Revenue by Country (2017-2028)
9.3.2 Brazil Adalimumab Drug Market Size and Forecast (2017-2028)
9.3.3 Argentina Adalimumab Drug Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Adalimumab Drug Revenue by Type (2017-2028)
10.2 Middle East & Africa Adalimumab Drug Revenue by Application (2017-2028)
10.3 Middle East & Africa Adalimumab Drug Market Size by Country
10.3.1 Middle East & Africa Adalimumab Drug Revenue by Country (2017-2028)
10.3.2 Turkey Adalimumab Drug Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Adalimumab Drug Market Size and Forecast (2017-2028)
10.3.4 UAE Adalimumab Drug Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Adalimumab Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Adalimumab Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Adalimumab Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Adalimumab Drug Revenue (USD Million) by Region (2017-2022)
Table 5. Global Adalimumab Drug Revenue Market Share by Region (2023-2028)
Table 6. Cambridge Antibody Technology Corporate Information, Head Office, and Major Competitors
Table 7. Cambridge Antibody Technology Major Business
Table 8. Cambridge Antibody Technology Adalimumab Drug Product and Solutions
Table 9. Cambridge Antibody Technology Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. BASF Corporate Information, Head Office, and Major Competitors
Table 11. BASF Major Business
Table 12. BASF Adalimumab Drug Product and Solutions
Table 13. BASF Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. AbbVie Corporate Information, Head Office, and Major Competitors
Table 15. AbbVie Major Business
Table 16. AbbVie Adalimumab Drug Product and Solutions
Table 17. AbbVie Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. MABURA Corporate Information, Head Office, and Major Competitors
Table 19. MABURA Major Business
Table 20. MABURA Adalimumab Drug Product and Solutions
Table 21. MABURA Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Exemptia Corporate Information, Head Office, and Major Competitors
Table 23. Exemptia Major Business
Table 24. Exemptia Adalimumab Drug Product and Solutions
Table 25. Exemptia Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Amgen Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Major Business
Table 28. Amgen Adalimumab Drug Product and Solutions
Table 29. Amgen Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Sandoz Corporate Information, Head Office, and Major Competitors
Table 31. Sandoz Major Business
Table 32. Sandoz Adalimumab Drug Product and Solutions
Table 33. Sandoz Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 35. Boehringer Ingelheim Major Business
Table 36. Boehringer Ingelheim Adalimumab Drug Product and Solutions
Table 37. Boehringer Ingelheim Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Mylan Corporate Information, Head Office, and Major Competitors
Table 39. Mylan Major Business
Table 40. Mylan Adalimumab Drug Product and Solutions
Table 41. Mylan Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Biogen Corporate Information, Head Office, and Major Competitors
Table 43. Biogen Major Business
Table 44. Biogen Adalimumab Drug Product and Solutions
Table 45. Biogen Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Adalimumab Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Adalimumab Drug Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Adalimumab Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Adalimumab Drug Players Head Office, Products and Services Provided
Table 50. Adalimumab Drug Mergers & Acquisitions in the Past Five Years
Table 51. Adalimumab Drug New Entrants and Expansion Plans
Table 52. Global Adalimumab Drug Revenue (USD Million) by Type (2017-2022)
Table 53. Global Adalimumab Drug Revenue Share by Type (2017-2022)
Table 54. Global Adalimumab Drug Revenue Forecast by Type (2023-2028)
Table 55. Global Adalimumab Drug Revenue by Application (2017-2022)
Table 56. Global Adalimumab Drug Revenue Forecast by Application (2023-2028)
Table 57. North America Adalimumab Drug Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Adalimumab Drug Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Adalimumab Drug Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Adalimumab Drug Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Adalimumab Drug Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Adalimumab Drug Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Adalimumab Drug Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Adalimumab Drug Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Adalimumab Drug Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Adalimumab Drug Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Adalimumab Drug Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Adalimumab Drug Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Adalimumab Drug Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Adalimumab Drug Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Adalimumab Drug Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Adalimumab Drug Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Adalimumab Drug Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Adalimumab Drug Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Adalimumab Drug Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Adalimumab Drug Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Adalimumab Drug Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Adalimumab Drug Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Adalimumab Drug Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Adalimumab Drug Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Adalimumab Drug Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Adalimumab Drug Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Adalimumab Drug Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Adalimumab Drug Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Adalimumab Drug Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Adalimumab Drug Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Adalimumab Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Adalimumab Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Adalimumab Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Adalimumab Drug Revenue (USD Million) by Region (2017-2022)
Table 5. Global Adalimumab Drug Revenue Market Share by Region (2023-2028)
Table 6. Cambridge Antibody Technology Corporate Information, Head Office, and Major Competitors
Table 7. Cambridge Antibody Technology Major Business
Table 8. Cambridge Antibody Technology Adalimumab Drug Product and Solutions
Table 9. Cambridge Antibody Technology Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. BASF Corporate Information, Head Office, and Major Competitors
Table 11. BASF Major Business
Table 12. BASF Adalimumab Drug Product and Solutions
Table 13. BASF Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. AbbVie Corporate Information, Head Office, and Major Competitors
Table 15. AbbVie Major Business
Table 16. AbbVie Adalimumab Drug Product and Solutions
Table 17. AbbVie Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. MABURA Corporate Information, Head Office, and Major Competitors
Table 19. MABURA Major Business
Table 20. MABURA Adalimumab Drug Product and Solutions
Table 21. MABURA Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Exemptia Corporate Information, Head Office, and Major Competitors
Table 23. Exemptia Major Business
Table 24. Exemptia Adalimumab Drug Product and Solutions
Table 25. Exemptia Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Amgen Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Major Business
Table 28. Amgen Adalimumab Drug Product and Solutions
Table 29. Amgen Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Sandoz Corporate Information, Head Office, and Major Competitors
Table 31. Sandoz Major Business
Table 32. Sandoz Adalimumab Drug Product and Solutions
Table 33. Sandoz Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 35. Boehringer Ingelheim Major Business
Table 36. Boehringer Ingelheim Adalimumab Drug Product and Solutions
Table 37. Boehringer Ingelheim Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Mylan Corporate Information, Head Office, and Major Competitors
Table 39. Mylan Major Business
Table 40. Mylan Adalimumab Drug Product and Solutions
Table 41. Mylan Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Biogen Corporate Information, Head Office, and Major Competitors
Table 43. Biogen Major Business
Table 44. Biogen Adalimumab Drug Product and Solutions
Table 45. Biogen Adalimumab Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Adalimumab Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Adalimumab Drug Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Adalimumab Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Adalimumab Drug Players Head Office, Products and Services Provided
Table 50. Adalimumab Drug Mergers & Acquisitions in the Past Five Years
Table 51. Adalimumab Drug New Entrants and Expansion Plans
Table 52. Global Adalimumab Drug Revenue (USD Million) by Type (2017-2022)
Table 53. Global Adalimumab Drug Revenue Share by Type (2017-2022)
Table 54. Global Adalimumab Drug Revenue Forecast by Type (2023-2028)
Table 55. Global Adalimumab Drug Revenue by Application (2017-2022)
Table 56. Global Adalimumab Drug Revenue Forecast by Application (2023-2028)
Table 57. North America Adalimumab Drug Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Adalimumab Drug Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Adalimumab Drug Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Adalimumab Drug Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Adalimumab Drug Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Adalimumab Drug Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Adalimumab Drug Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Adalimumab Drug Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Adalimumab Drug Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Adalimumab Drug Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Adalimumab Drug Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Adalimumab Drug Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Adalimumab Drug Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Adalimumab Drug Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Adalimumab Drug Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Adalimumab Drug Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Adalimumab Drug Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Adalimumab Drug Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Adalimumab Drug Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Adalimumab Drug Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Adalimumab Drug Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Adalimumab Drug Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Adalimumab Drug Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Adalimumab Drug Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Adalimumab Drug Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Adalimumab Drug Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Adalimumab Drug Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Adalimumab Drug Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Adalimumab Drug Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Adalimumab Drug Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Adalimumab Drug Picture
Figure 2. Global Adalimumab Drug Revenue Market Share by Type in 2021
Figure 3. Adalimumab
Figure 4. Adalimumab Biosimilar
Figure 5. Adalimumab Drug Revenue Market Share by Application in 2021
Figure 6. Adult Picture
Figure 7. Children Picture
Figure 8. Global Adalimumab Drug Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Adalimumab Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Adalimumab Drug Revenue Market Share by Region (2017-2028)
Figure 11. Global Adalimumab Drug Revenue Market Share by Region in 2021
Figure 12. North America Adalimumab Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Adalimumab Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Adalimumab Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Adalimumab Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Adalimumab Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Adalimumab Drug Market Drivers
Figure 18. Adalimumab Drug Market Restraints
Figure 19. Adalimumab Drug Market Trends
Figure 20. Cambridge Antibody Technology Recent Developments and Future Plans
Figure 21. BASF Recent Developments and Future Plans
Figure 22. AbbVie Recent Developments and Future Plans
Figure 23. MABURA Recent Developments and Future Plans
Figure 24. Exemptia Recent Developments and Future Plans
Figure 25. Amgen Recent Developments and Future Plans
Figure 26. Sandoz Recent Developments and Future Plans
Figure 27. Boehringer Ingelheim Recent Developments and Future Plans
Figure 28. Mylan Recent Developments and Future Plans
Figure 29. Biogen Recent Developments and Future Plans
Figure 30. Global Adalimumab Drug Revenue Share by Players in 2021
Figure 31. Adalimumab Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Adalimumab Drug Revenue Market Share in 2021
Figure 33. Global Top 10 Players Adalimumab Drug Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Adalimumab Drug Revenue Share by Type in 2021
Figure 36. Global Adalimumab Drug Market Share Forecast by Type (2023-2028)
Figure 37. Global Adalimumab Drug Revenue Share by Application in 2021
Figure 38. Global Adalimumab Drug Market Share Forecast by Application (2023-2028)
Figure 39. North America Adalimumab Drug Sales Market Share by Type (2017-2028)
Figure 40. North America Adalimumab Drug Sales Market Share by Application (2017-2028)
Figure 41. North America Adalimumab Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Adalimumab Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Adalimumab Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Adalimumab Drug Revenue Market Share by Country (2017-2028)
Figure 48. Germany Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Adalimumab Drug Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Adalimumab Drug Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Adalimumab Drug Revenue Market Share by Region (2017-2028)
Figure 56. China Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Adalimumab Drug Sales Market Share by Type (2017-2028)
Figure 63. South America Adalimumab Drug Sales Market Share by Application (2017-2028)
Figure 64. South America Adalimumab Drug Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Adalimumab Drug Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Adalimumab Drug Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Adalimumab Drug Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Adalimumab Drug Picture
Figure 2. Global Adalimumab Drug Revenue Market Share by Type in 2021
Figure 3. Adalimumab
Figure 4. Adalimumab Biosimilar
Figure 5. Adalimumab Drug Revenue Market Share by Application in 2021
Figure 6. Adult Picture
Figure 7. Children Picture
Figure 8. Global Adalimumab Drug Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Adalimumab Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Adalimumab Drug Revenue Market Share by Region (2017-2028)
Figure 11. Global Adalimumab Drug Revenue Market Share by Region in 2021
Figure 12. North America Adalimumab Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Adalimumab Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Adalimumab Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Adalimumab Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Adalimumab Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Adalimumab Drug Market Drivers
Figure 18. Adalimumab Drug Market Restraints
Figure 19. Adalimumab Drug Market Trends
Figure 20. Cambridge Antibody Technology Recent Developments and Future Plans
Figure 21. BASF Recent Developments and Future Plans
Figure 22. AbbVie Recent Developments and Future Plans
Figure 23. MABURA Recent Developments and Future Plans
Figure 24. Exemptia Recent Developments and Future Plans
Figure 25. Amgen Recent Developments and Future Plans
Figure 26. Sandoz Recent Developments and Future Plans
Figure 27. Boehringer Ingelheim Recent Developments and Future Plans
Figure 28. Mylan Recent Developments and Future Plans
Figure 29. Biogen Recent Developments and Future Plans
Figure 30. Global Adalimumab Drug Revenue Share by Players in 2021
Figure 31. Adalimumab Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Adalimumab Drug Revenue Market Share in 2021
Figure 33. Global Top 10 Players Adalimumab Drug Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Adalimumab Drug Revenue Share by Type in 2021
Figure 36. Global Adalimumab Drug Market Share Forecast by Type (2023-2028)
Figure 37. Global Adalimumab Drug Revenue Share by Application in 2021
Figure 38. Global Adalimumab Drug Market Share Forecast by Application (2023-2028)
Figure 39. North America Adalimumab Drug Sales Market Share by Type (2017-2028)
Figure 40. North America Adalimumab Drug Sales Market Share by Application (2017-2028)
Figure 41. North America Adalimumab Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Adalimumab Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Adalimumab Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Adalimumab Drug Revenue Market Share by Country (2017-2028)
Figure 48. Germany Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Adalimumab Drug Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Adalimumab Drug Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Adalimumab Drug Revenue Market Share by Region (2017-2028)
Figure 56. China Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Adalimumab Drug Sales Market Share by Type (2017-2028)
Figure 63. South America Adalimumab Drug Sales Market Share by Application (2017-2028)
Figure 64. South America Adalimumab Drug Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Adalimumab Drug Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Adalimumab Drug Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Adalimumab Drug Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Adalimumab Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
